
Mike Ward
Michael P. Ward, Senior Director of Strategy and Partnerships (formerly Head of Sales) at Firefly Neuroscience, maker of the FDA-cleared AI-powered brain health platform BNA.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
Sep 27, 2026
EEG + Monarch eTNS for ADHD? Mike Ward From Firefly Neuroscience Joins With News.
1:12
1:17
1:42

Mike WardGUEST
So, you know, it made complete sense to partner with Collin when we reached out a few weeks ago.

Mike WardGUEST
So last March, Firefly, we made a press release where we announced that we identified students EEG and ERP biomarkers where we actually can identify the difference between the inattentive type, the hyperactive arousal type, or if someone actually doesn't have ADHD and maybe just has insomnia or sleep issues, which happens quite frequently, we come to find out from many of our psychiatrists.

Mike WardGUEST
So we took all of our microdata and with the mind of Dave DiCaprio, who went to MIT and is a trained engineer and data scientist, and won the CMS AI challenge a few years ago, we incorporated AI into our Firefly reports that when a provider does a 20-minute EEG with Firefly, one of the first things that will pop up on that report is actually an AI analysis on the cognitive biomarker findings and what type of biomarkers a patient may or may not have indicating the type of ADHD, all of which is designed to help a provider read and interpret that report.
5 MINS LATER
